Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07308860 · ClinicalTrials.gov registry record

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

A clinical trial of Coronary Artery Disease, sponsored by Stanford University.

Active
Registry status
1,500
Enrollment target
1
Study location

NCT07308860: Active study of Coronary Artery Disease, sponsored by Stanford University.

NCT07308860 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 1,500 participants, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07308860, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Coronary artery disease, or narrowing of the blood vessels that provide blood to the heart, is the most common cause of death in the United States and can be treated with either coronary bypass surgery or coronary stent placement. This study will evaluate outcomes, including death and quality of life, at 10 years in 1,500 patients with coronary disease who have already been randomized to either bypass surgery or stenting.

Primary Outcome

The primary outcome is mortality or overall survival

Conditions Studied

Coronary Artery Disease

Interventions

  • PROCEDURE FFR-guided PCI
  • PROCEDURE CABG

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-08-01
Est. Completion 2030-06-30
Stanford University

1,744 total trials

What the registry record for NCT07308860 still lists

NCT07308860 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which FFR-guided PCI is the first listed.

NCT07308860 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07308860 about?

NCT07308860 is a clinical study titled "Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended". Coronary artery disease, or narrowing of the blood vessels that provide blood to the heart, is the most common cause of death in the United States and can be treated with either coronary bypass surgery or coronary stent placement. This study will evaluate outcomes, including death and quality of lif...

What is the current status of trial NCT07308860?

This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2025-08-01. Estimated completion is 2030-06-30.

What conditions does trial NCT07308860 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT07308860?

The interventions under investigation include: FFR-guided PCI (PROCEDURE), CABG (PROCEDURE).

Who is sponsoring clinical trial NCT07308860?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07308860 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07308860's enrollment target sits among peer trials

1,500 37th of 219 higher than 182 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT07308860, the US trial registry maintained by the National Library of Medicine. NCT07308860 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.